Matsumoto, Japan

Yukio Kamijo


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 58(Granted Patents)


Location History:

  • Matsumoto, JP (1980 - 1982)
  • Nagano, JP (1986)

Company Filing History:


Years Active: 1980-1986

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yukio Kamijo: Innovator in Pharmaceutical Chemistry

Introduction

Yukio Kamijo is a notable inventor based in Matsumoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of imidazole derivatives. With a total of 3 patents to his name, his work has had a profound impact on therapeutic applications.

Latest Patents

Kamijo's latest patents focus on imidazole derivatives and their pharmaceutical uses. One of his notable inventions involves imidazole derivatives that exhibit a strong inhibitory effect on thromboxane synthetase from human or bovine platelet microsomes. These compounds are useful in treating conditions such as inflammation, hypertension, thrombus, cerebral apoplexy, and asthma. Another patent details the inhibition of thromboxane synthetase with 1-substituted imidazole, which also shows therapeutic potential for similar health issues.

Career Highlights

Throughout his career, Yukio Kamijo has worked with prominent companies in the pharmaceutical industry, including Kissei Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. His expertise in medicinal chemistry has led to advancements in drug development and therapeutic solutions.

Collaborations

Kamijo has collaborated with esteemed colleagues such as Kinji Iizuka and Denichi Momose. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Yukio Kamijo's contributions to pharmaceutical chemistry, particularly through his patents on imidazole derivatives, highlight his role as a key innovator in the field. His work continues to influence therapeutic practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…